BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.880
+0.010 (0.35%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Company Description

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.

The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.

Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing.

The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases.

It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp.
BioNexus Gene Lab logo
Country Malaysia
Founded 2017
Industry Specialty Chemicals
Sector Materials
Employees 30
CEO Su-Leng Tan

Contact Details

Address:
Tower B, Avenue 3, Unit 02, Level 10
Kuala Lumpur, 59200
Malaysia
Phone 60 1 307 241 6898
Website bionexusgenelab.com

Stock Details

Ticker Symbol BGLC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001737523
CUSIP Number 090628108
ISIN Number US0906282076
Employer ID 26-2124961
SIC Code 8071

Key Executives

Name Position
Su-Leng Tan Chief Executive Officer, President, Acting Chief Financial Officer, Secretary and Director
Kwan Wah Chan Marketing Manager
Too Kam Tham Managing Director

Latest SEC Filings

Date Type Title
Apr 15, 2025 10-K Annual Report
Apr 10, 2025 8-K Current Report
Apr 3, 2025 8-K Current Report
Mar 31, 2025 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 25, 2025 8-K Current Report
Mar 7, 2025 8-K Current Report
Mar 5, 2025 8-K Current Report
Feb 28, 2025 DEFR14A Filing
Feb 27, 2025 DEF 14A Other definitive proxy statements
Feb 14, 2025 8-K Current Report